THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Patent Owner
Stats
- 89 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Jan 25, 2018 most recent publication
Details
- 89 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,225 Total Citation Count
- Jul 29, 1994 Earliest Filing
- 79 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0273,581 DETECTION OF PATENT DUCTUS ARTERIOSUS USING PHOTOPLETHYSMOGRAPHYAug 27, 15Sep 28, 17[A61B]
2016/0113,518 MICROCHIP SENSOR FOR CONTINUOUS MONITORING OF REGIONAL BLOOD FLOWOct 21, 15Apr 28, 16[A61B]
2012/0128,586 METHOD FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIAJun 24, 10May 24, 12[A61K, C07H, C12Q, C12N, A61P, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9745364 Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemiaJan 20, 12Aug 29, 17[G01N, C07K]
9683265 CD38 as a prognostic indicator in B cell chronic lymphocytic leukemiaJun 29, 16Jun 20, 17[A61K, C12Q, C12N, G01N]
9662490 Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drugDec 11, 15May 30, 17[A61N]
9592228 Treatment of inflammation using alpha 7 receptor-binding agonistsSep 03, 15Mar 14, 17[A61K, A01N, G01N]
9567306 Inhibition of macrophage migration inhibitory factor in melanoma and colon cancerJun 16, 15Feb 14, 17[A61K, C07D, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0129,946 HMG1 Antibody For Treating Inflammatory ConditionsAbandonedJan 21, 16May 11, 17[A61K, C07K]
2016/0287,533 Activity Enhancing Curcumin Compositions and Methods of UseAbandonedNov 28, 14Oct 06, 16[A61K]
2016/0250,097 TREATMENT OF INFLAMMATION BY NON-INVASIVE STIMULATIONAbandonedMar 13, 08Sep 01, 16[A61H]
2014/0336,476 MICROCHIP SENSOR FOR CONTINUOUS MONITORING OF REGIONAL BLOOD FLOWAbandonedOct 26, 12Nov 13, 14[A61B]
2014/0193,412 TREATMENT OF CUTANEOUS WOUNDS BY INHIBITING COLD SHOCK PROTEINSAbandonedJan 10, 14Jul 10, 14[A61K, C07K]
2014/0128,692 FLEXIBLE SPIRALLY-ROLLED POLYMER TUBE FOR MONITORING AND TREATMENT OF BRAIN INJURIESAbandonedJan 10, 14May 08, 14[A61B, A61M]
8628493 Flexible spirally-rolled polymer tube for monitoring and treatment of brain injuriesExpiredJun 03, 09Jan 14, 14[A61K, A61M]
2013/0317,040 METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING HIV PROTEASE INHIBITORSAbandonedDec 21, 11Nov 28, 13[A61K]
8586296 Method to identify and predict disease progression of human papilloma virus-infected lesionsExpiredDec 20, 10Nov 19, 13[C07H, C12Q]
8524866 Antibodies to the alpha-7 nicotinic receptors and methods of treating inflammatory disorders with the sameExpiredNov 15, 06Sep 03, 13[A61K, C12P, C07K]
8501173 Antibodies to high mobility group-1(HMGB1) B-box polypeptidesExpiredJan 11, 11Aug 06, 13[A61K]
2013/0096,048 TREATMENT OF SEPSIS AND SEPTIC SHOCK USING GHRELIN AND GROWTH HORMONEAbandonedDec 03, 12Apr 18, 13[A61K]
8420309 Method of screening compounds using CALHM (FAM26C)ExpiredAug 08, 08Apr 16, 13[A61K, C12Q, A61P, C40B, C07K]
8129130 High affinity antibodies against HMGB1 and methods of use thereofExpiredMar 18, 11Mar 06, 12[G01N]
2011/0293,640 Cholinesterase Inhibitors for Treating InflammationAbandonedMay 27, 11Dec 01, 11[A61K]
2011/0245,286 TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING AGONISTSAbandonedFeb 01, 11Oct 06, 11[A61K, A61P]
2011/0236,406 IMMUNOGENIC COMPOSITIONS COMPRISING HMGB1 POLYPEPTIDESAbandonedJan 18, 11Sep 29, 11[A61K, C12N, A61P, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.